GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (TSXV:RTI.H) » Definitions » Capex-to-Revenue

Radient Technologies (TSXV:RTI.H) Capex-to-Revenue : 0.00 (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Radient Technologies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Radient Technologies's Capital Expenditure for the three months ended in Dec. 2022 was C$0.00 Mil. Its Revenue for the three months ended in Dec. 2022 was C$1.03 Mil.

Hence, Radient Technologies's Capex-to-Revenue for the three months ended in Dec. 2022 was 0.00.


Radient Technologies Capex-to-Revenue Historical Data

The historical data trend for Radient Technologies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Capex-to-Revenue Chart

Radient Technologies Annual Data
Trend Dec13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.91 61.23 0.61 0.05 0.44

Radient Technologies Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Radient Technologies's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radient Technologies's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Radient Technologies's Capex-to-Revenue falls into.



Radient Technologies Capex-to-Revenue Calculation

Radient Technologies's Capex-to-Revenue for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.578) / 3.622
=0.44

Radient Technologies's Capex-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 1.029
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radient Technologies  (TSXV:RTI.H) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Radient Technologies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Radient Technologies (TSXV:RTI.H) Business Description

Traded in Other Exchanges
N/A
Address
4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4
Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.

Radient Technologies (TSXV:RTI.H) Headlines

No Headlines